Nobody really tells you this, but the hardest part of med school isn’t the science. It’s everything piling on at once – the sheer amount of material, the constant pressure, the way you start becoming a different person, and this exhaustion that sneaks up on you. You don’t even notice it until one day you […]
The post Challenges Medical Students Face During Studies appeared first on Medical News Bulletin.
A review of existing clinical trials pitting psychedelic-assisted therapy against regular antidepressants suggests that psychedelics are not quite the panacea proponents of the treatment had hoped.
The post Bulletin: Psychedelic success more placebo than palliative? appeared first on Medical News Bulletin.
Survival in emergencies depends on fast and correct action. Many cases show that early care changes outcomes. This is why survival rates and medical response are closely linked. Every second matters when a patient is in distress. Trained responders can reduce complications and save lives. Better systems also support quicker decisions in critical moments. Explore […]
The post Improving Survival Rates Through Advanced Medical Response appeared first on Medical News Bulletin.
Influenza vaccination continues to protect children from influenza-related outpatient visits and hospitalizations, according to post-pandemic data published in Pediatrics.
“We have had really severe recent seasons for flu, particularly in children,” Samantha M. Olson, MPH, an epidemiologist in the CDC’s influenza division, told Healio in an interview. “This study really adds to the growing body of evidence showing how protective flu vaccines can be for infants, children and adolescents, and this includes even the most severe outcomes.”
Olson and colleagues used data from seven pediatric medical
Acting U.S. Attorney General Todd Blanche today signed an order easing restrictions on state-licensed and FDA-approved medical marijuana, reclassifying them as less dangerous than drugs such as heroin.
According to a press release from the U.S. Department of Justice (DOJ), the order reclassifies these marijuana products from Schedule I to Schedule III.
Schedule I drugs are substances with “no currently accepted medical use and a high potential for abuse,” the U.S. Drug Enforcement Administration (DEA)’s website states, while Schedule III drugs have a “moderate to low potential for physical and
Across the country, there is an increase in same day discharge and outpatient total joint arthroplasty programs.
But according to Ugo N. Ihekweazu, MD, FAAOS, FAAHKS, chief of adult hip and knee reconstruction at Texas Orthopedic Hospital and a partner of the Fondren Orthopedic Group in Houston, Texas, the trend is only natural.
“It is a natural evolution of joint replacement that has been driven by better implants, less invasive surgical techniques, better anesthesia pathways and pain control,” Ihekweazu told Healio. “The other thing that comes with it is that patients like
Sleep duration may have a significant impact on cancer risk.
Data presented at American Association for Cancer Research Annual Meeting showed individuals who slept less than 7 to 8 hours per night had slightly lower risk for overall cancer development, and particularly for breast, lung, and skin cancers.
However, they also had a 22% increased risk for cancer of the small intestine and 14% increased risk of acute myeloid leukemia.
Head and neck cancer risk significantly increased among individuals who had short sleep, duration, too.
The findings highlight the “complex” association between sleep
A strategy of using a drug-eluting balloon with minimal stenting was noninferior compared with systematic drug-eluting stent use for treatment of acute coronary syndrome, a speaker reported.
A sirolimus-eluting balloon (Selution SLR, MedAlliance/Cordis) with minimal stenting was a safe alternative to DES use at 1 year for patients who presented with non-STEMI or unstable angina, according to the results of the SELUTION DeNovo study presented at the Society for Cardiovascular Angiography & Interventions Scientific Sessions & Canadian Association of Interventional Cardiology/Association
LAS VEGAS — Adults with osteoporosis prescribed the antiresorptive denosumab were no more likely to sustain an atypical femur fracture compared with bisphosphonate users over 4 years, according to data from a large, real-world study.
Long-term use of bisphosphonates, the first-line therapy for osteoporosis, is associated with rare but serious atypical femur fractures, which come with a high clinical burden that include delayed healing and significant morbidity, Haolan Qi, MD, MSc, a masters student in epidemiology at McGill University in Montreal, said during a presentation at the American
The FDA approved dupilumab to treat children aged 2 to 11 years with chronic spontaneous urticaria and persistent symptoms despite H1 antihistamine treatment, according to a company press release.
The FDA’s decision expands the April 2025 approval of dupilumab (Dupixent, Regeneron/Sanofi) for chronic spontaneous urticaria (CSU) in adults and adolescents aged 12 years and older.
“Before this approval, only antihistamines were approved for children younger than 12 years of age. Since about 50% of patients do not adequately respond to antihistamines alone, this leads to a gap in the treatment of